M&As in domestic pharmaceutical sector will go up

Published: 2012-12-07 07:00:00

Updated: 2012-12-07 07:00:00

Pharmaceutical companies could benefit from mergers and acquisitions (M&As) in the changing business environment of the 21st century, according to a research institute said Wednesday.

In a conference hosted by Korea Pharmaceutical Manufacturers Association, Samjung KPMG official Park Seung-hyu...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK